- ►annals.org [PDF] TJ Kaptchuk - Annals of Internal Medicine, 2002 - Am Coll Physicians In alternative medicine, the main question regarding placebo has been whether a
given therapy has more than a placebo effect. Just as mainstream medicine
ignores the clinical significance of its own placebo effect, the placebo ... Cited by 160 - Related articles - BL Direct - All 7 versions
- ►annals.org DE Moerman, WB Jonas - Annals of Internal Medicine, 2002 - Am Coll Physicians We provide a new perspective with which to understand what for a half century
has been known as the "placebo effect." We argue that, as currently used, the
concept includes much that has nothing to do with placebos, confusing the ... Cited by 201 - Related articles - All 13 versions
TJ Kaptchuk, P Goldman, DA Stone, WB … - Journal of Clinical Epidemiology, 2000 - Elsevier Although the placebo in a clinical trial is often considered simply a baseline
against which to evaluate the efficacy of a clinical intervention, there is
evidence that the magnitude of placebo effect may be a critical factor in ... Cited by 155 - Related articles - BL Direct - All 8 versions
TJ Kaptchuk - LANCET-LONDON-, 1998 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Powerful placebo: the dark
side of the randomised controlled trial. Author: Kaptchuk, TJ Citation: Lancet. ... Cited by 152 - Related articles - Cached - BL Direct - All 4 versions
C Paterson, P Dieppe - British Medical Journal, 2005 - bmj.com The randomised double blind controlled trial has proved an invaluable tool for
testing the efficacy of new drugs. However, it is now used to evaluate complex
non-pharmaceutical interventions, many of which are based on different ... Cited by 134 - Related articles - All 8 versions
- ►imp.ch [PDF] F Porzsolt, N Scholtz-Gorton, N Biller- … - Science and Engineering Ethics, 2004 - Springer ABSTRACT : Using placebos in day-to-day practice is an ethical problem. This
paper summarises the available epidemiological evidence to support this
difficult decision. Based on these data we propose to differentiate between ... Cited by 16 - Related articles - BL Direct - All 5 versions
AJM de Craen, DE Moerman, SH Heisterkamp, … - British journal of clinical pharmacology, 1999 - pubmedcentral.nih.gov Correspondence: Dr Anton JM de Craen Department of Clinical Epidemiology Leiden
University Medical Centre PO Box 9600, 2300 RC Leiden, The Netherlands. Tel.:
+31–71–5264037, Fax: +31 71 5248122, E-mail: AJMdeCraen/at/epi.azl.nl. Cited by 53 - Related articles - BL Direct - All 4 versions
YG Papakostas, MD Daras - Epilepsia, 2001 - interscience.wiley.com Summary: In spite of its impressive progress, medicine has been strongly
criticized for relying on its modern biomedical tradition to the neglect of the
psychosocial aspects of health. This neglect may account for patients' ... Cited by 43 - Related articles - BL Direct - All 5 versions
K Linde, A Streng, S Jurgens, A Hoppe, B … - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Acupuncture is ... Cited by 162 - Related articles - All 8 versions
A Hróbjartsson - Journal of clinical epidemiology, 2002 - Elsevier Researchers disagree whether placebo effects are clinically important. The
controversy is partly due to conceptual and methodological problems. The
objective of this paper is to analyze the main methodological problems in ... Cited by 69 - Related articles - BL Direct - All 9 versions
